Neurovascular pathways and Alzheimer amyloid beta-peptide.
about
beta-Amyloid degradation and Alzheimer's diseaseApoE promotes the proteolytic degradation of AbetaAPOE ε4 genotype predicts memory for everyday activitiesImpaired structural correlates of memory in Alzheimer's disease mice.Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous systemThe use of recently developed histochemical markers for localizing neurotoxicant induced regional brain pathologies.Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease.Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brainBinding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy.Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's diseaseScreening for cognitive decline following single known stroke using the Mini-Mental State Examination.Hypertension and cognitive functionDonepezil in Alzheimer's disease: an evidence-based review of its impact on clinical and economic outcomes.Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.Learning on Jupiter, learning on the Moon: the dark side of the G-force. Effects of gravity changes on neurovascular unit and modulation of learning and memoryNeurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.HDL-cholesterol and apolipoproteins in relation to dementia.Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.Pathology and pathogenesis of vascular cognitive impairment-a critical updateBlood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.Inflammaging as a prodrome to Alzheimer's diseaseCerebral perfusion and oxygenation differences in Alzheimer's disease riskThe blood-brain barrier in neurodegenerative disease: a rhetorical perspective.Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma.Obstructive Sleep Apnea is Linked to Depression and Cognitive Impairment: Evidence and Potential Mechanisms.Role of serum response factor in the pathogenesis of disease.Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and diseasePathogenesis and treatment of vascular cognitive impairment.Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.Relationship between cognitive function and regulation of cerebral blood flow.Amyloid beta: structure, biology and structure-based therapeutic development.Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's diseaseEndoplasmic Reticulum Malfunction in the Nervous System.apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer's disease.Apolipoproteins and Alzheimer's pathophysiology
P2860
Q21284467-D522C4E1-D999-4E2B-B97F-A4842541BA73Q24651102-2CA53E34-DE01-4636-A3B3-D998C0A6781FQ30661353-176E1AA9-5D69-43DA-85CE-16AE23EA1F9AQ30701096-57C435BA-55F3-4727-A109-DEC24AF8607FQ33262322-05F6BF51-9471-4AC8-BDC2-61A37F69D437Q33584889-6F1BE613-E029-49D8-B90E-771EFEE5639FQ33809087-E3A510A8-4E29-4477-88C3-F0BA7C436715Q34268519-AE891610-FBA6-4045-A09F-FC8672121327Q34329102-D890E8E5-AF56-4176-A336-75D3B1F5E5AEQ34873879-EAF549E4-C0A6-4AF2-8635-891F6C9A8C6FQ34956402-85E6E6ED-5AE9-4AD3-8787-3A6F40ECD91AQ35178724-D841AC5A-68CC-4BAB-9791-61057E692600Q35876403-94C68FF9-EC29-409B-A95C-3C2D91D29304Q36205039-BA7E5A52-7507-4D26-84DF-72737D7FE51EQ36208400-0216F97B-C476-4C95-A1D4-6FDEA786A5F4Q36254073-01281A78-209E-49F0-93E5-1A18BA0E5E1FQ36343094-C4481593-05FC-446D-A4DE-5141CDB16AA5Q36436743-93A10551-7CA2-4665-85A1-0A797294046BQ36622848-D10D72E2-D167-4203-9CD3-12C0DC250A89Q36754568-46E51CF6-21BD-425D-AE0A-894404684687Q36822317-AAFE7D5E-D290-4BB4-AA28-4805FC9458FAQ37041389-8F11DD9C-D1DA-4331-845B-F5990496AA73Q37353455-DA058C35-8F22-4109-8A7B-66393AD81626Q37385549-F8926FBE-B370-4FD5-93F0-7DC1E97C94CEQ37682703-19CCE92A-4FE0-4937-A64E-68BE8FA8A95AQ37738390-F959877C-5220-49BB-8FEF-5731936D007DQ37760418-6B2FA97C-60AE-456B-84F6-9B2FDACB4FE2Q37781281-7DD55A68-BBFD-4D0E-83BA-26B8B58A7F23Q38297016-F23C1022-AF4E-458F-A3E7-B2F132D972E9Q38781022-A16FDDAD-4E05-4593-B172-C1835514B59EQ39069181-F8F8CA60-00ED-4075-995B-6ACBFA8C7742Q39117015-A39DF539-2D92-41CD-AEF6-DCD90B858B15Q39437881-B75CBCE1-EDF9-4282-8F40-C1EFA6BDAB18Q42044152-E14ACEFD-0CF3-4C88-AFCA-BE5BF823D8C2Q42290598-DECEF985-0598-4C92-AF3F-0281DEBAD5F4Q43243545-BE75C259-CE07-4EC8-88CA-04198D998794Q43249667-6BB2CA9B-9464-43F6-98D3-6F78BBED2B19Q58129974-31C1D655-EC6F-484B-A599-8A92E4A5C8C4
P2860
Neurovascular pathways and Alzheimer amyloid beta-peptide.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Neurovascular pathways and Alzheimer amyloid beta-peptide.
@ast
Neurovascular pathways and Alzheimer amyloid beta-peptide.
@en
type
label
Neurovascular pathways and Alzheimer amyloid beta-peptide.
@ast
Neurovascular pathways and Alzheimer amyloid beta-peptide.
@en
prefLabel
Neurovascular pathways and Alzheimer amyloid beta-peptide.
@ast
Neurovascular pathways and Alzheimer amyloid beta-peptide.
@en
P2093
P1433
P1476
Neurovascular pathways and Alzheimer amyloid beta-peptide.
@en
P2093
Berislav V Zlokovic
Jan Sallstrom
Joseph M Miano
Nienwen Chow
Rashid Deane
P2860
P356
10.1111/J.1750-3639.2005.TB00103.X
P577
2005-01-01T00:00:00Z